EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The great obstetrical syndromes and the placenta

Matthew K Hoffman

BJOG: An International Journal of Obstetrics & Gynaecology · 2023-11 · 130 (S3) · 8-15

DOI: 10.1111/1471-0528.17613 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 02.08.2023. Verfasst von Matthew K Hoffman. Beteiligte Einrichtung: Departments of Obstetrics and Gynecology, Christiana Care Health Services, Newark, Delaware, USA. Hauptthemen laut MEDLINE: Pre-Eclampsia, Premature Birth, Thrombosis. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although historically pre‐eclampsia, preterm birth, abruption, fetal growth restriction and stillbirth have been viewed as clinically distinct entities, a growing body of literature has demonstrated that the placenta and its development is the root cause of many cases of these conditions. This has led to the term ‘the great obstetrical syndromes’ being coined to reflect this common origin. Although these conditions mostly manifest in the second half of pregnancy, a failure to complete deep placentation (the transition from histiotrophic placentation to haemochorial placenta at 10–18 weeks of gestation via a second wave of extravillous trophoblast invasion), is understood to be key to the pathogenesis of the great obstetrical syndromes. While the reasons that the placenta fails to achieve deep placentation remain active areas of investigation, maternal inflammation and thrombosis have been clearly implicated. From a clinical standpoint these mechanisms provide a biological explanation of how low‐dose aspirin, which affects the COX‐1 receptor (thrombosis) and the COX‐2 receptor (inflammation), prevents not just pre‐eclampsia but all the components of the great obstetrical syndromes if initiated early in pregnancy. The optimal dose of low‐dose aspirin that is maximally effective in pregnancy remains a question open for further research. Additionally, other candidate medications have been identified that may also prevent pre‐eclampsia, and further study of them may offer therapeutic options beyond low‐dose aspirin. Interestingly, three of the eight identified compounds (hydroxychloroquine, metformin and pravastatin) are known to decrease inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaPremature BirthThrombosisPregnancyFemaleInfant, NewbornHumansPlacentaAspirinInflammation

Stichwörter der Autor:innen

aspiringreat obstetrical syndromesinflammationplacentapre-eclampsiapreterm

Substanzen

Aspirin

Autor:innen und Institutionen

  • Departments of Obstetrics and Gynecology, Christiana Care Health Services, Newark, Delaware, USA.

Förderung

  • NICHD NIH HHS

Zitieren

APA

Hoffman, M. K. (2023). The great obstetrical syndromes and the placenta. BJOG: An International Journal of Obstetrics & Gynaecology, 130(S3), 8-15. https://doi.org/10.1111/1471-0528.17613

Vancouver

Hoffman MK. The great obstetrical syndromes and the placenta. BJOG: An International Journal of Obstetrics & Gynaecology. 2023;130(S3):8-15. doi:10.1111/1471-0528.17613

BibTeX
@article{Hoffman2023,
  author = {Hoffman, Matthew K},
  title = {The great obstetrical syndromes and the placenta},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2023},
  volume = {130},
  number = {S3},
  pages = {8--15},
  doi = {10.1111/1471-0528.17613}
}
Kostenlos starten →